Reviewing Antiviral Research against Viruses Causing Human Diseases - a Structure-Guided Approach
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F22%3A00557951" target="_blank" >RIV/61388963:_____/22:00557951 - isvavai.cz</a>
Result on the web
<a href="https://doi.org/10.2174/1874467214666210804152836" target="_blank" >https://doi.org/10.2174/1874467214666210804152836</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/1874467214666210804152836" target="_blank" >10.2174/1874467214666210804152836</a>
Alternative languages
Result language
angličtina
Original language name
Reviewing Antiviral Research against Viruses Causing Human Diseases - a Structure-Guided Approach
Original language description
The smallest of all the pathogens, viruses, have continuously been the foremost strange microorganisms. Viral infections can cause extreme sicknesses as evidenced by the HIV/AIDS widespread or the later Ebola or Zika episodes. Apprehensive framework distortions are also regularly observed as consequences of numerous viral infections. Besides, numerous viral infections are of oncoviruses, which can trigger different types of cancer. Nearly every year, a modern infectious species emerges, debilitating the world population with an annihilating episode. Subsequently, there is a need to create antivirals to combat such rising infections. From the discovery of the antiviral drug Idoxuridine in 1962 to the revelation of Baloxavir marboxil (Xofluza) that was approved by the FDA in 2018, the whole process and criteria of creating antivirals have changed significantly. In this article, different auxiliary science strategies are described that can serve as a referral for therapeutic innovation.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10607 - Virology
Result continuities
Project
<a href="/en/project/EF16_019%2F0000729" target="_blank" >EF16_019/0000729: Chemical biology for drugging undruggable targets</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2022
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Current Molecular Pharmacology
ISSN
1874-4672
e-ISSN
1874-4702
Volume of the periodical
15
Issue of the periodical within the volume
2
Country of publishing house
AE - UNITED ARAB EMIRATES
Number of pages
32
Pages from-to
306-337
UT code for WoS article
000819380800004
EID of the result in the Scopus database
2-s2.0-85130861968